![]() |
Volumn 45, Issue 11, 2002, Pages 2173-2184
|
An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (5 METHYL 5 MORPHOLINOCARBONYL 1,3 DIOXAN 2 YL) 5 (4 PYRIDINYL)IMIDAZOLE;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;
SYNAPTOPHYSIN;
UNCLASSIFIED DRUG;
ALGORITHM;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTHRITIS;
ARTICLE;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG POTENCY;
DRUG SYNTHESIS;
FEMALE;
ISOMER;
MONTE CARLO METHOD;
NONHUMAN;
PAW EDEMA;
RAT;
SOLID PHASE EXTRACTION;
ADMINISTRATION, ORAL;
ALGORITHMS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, EXPERIMENTAL;
BIOLOGICAL AVAILABILITY;
CACO-2 CELLS;
CELL LINE;
COMBINATORIAL CHEMISTRY TECHNIQUES;
DIOXANES;
ENZYME INHIBITORS;
HUMANS;
IMIDAZOLES;
MICE;
MICE, INBRED BALB C;
MITOGEN-ACTIVATED PROTEIN KINASES;
MONOCYTES;
MONTE CARLO METHOD;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PIPERAZINES;
PYRIMIDINES;
RATS;
RATS, INBRED LEW;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0037161596
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm011132l Document Type: Article |
Times cited : (92)
|
References (31)
|